BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+0.1%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$2.95B
AUM Growth
+$2.95B
(-14%)
Cap. Flow
-$147M
Cap. Flow
% of AUM
-4.99%
Top 10 Holdings %
Top 10 Hldgs %
70.08%
Holding
59
New
4
Increased
11
Reduced
13
Closed
6
Top Buys
| 1 |
SEPN
Septerna, Inc. Common Stock
SEPN
|
$56.2M |
| 2 |
VERV
Verve Therapeutics
VERV
|
$35.3M |
| 3 |
Xencor
XNCR
|
$33.1M |
| 4 |
Revolution Medicines
RVMD
|
$30.7M |
| 5 |
Axsome Therapeutics
AXSM
|
$28.9M |
Top Sells
| 1 |
MoonLake Immunotherapeutics
MLTX
|
$108M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$58.2M |
| 3 |
IDEAYA Biosciences
IDYA
|
$44.7M |
| 4 |
CG Oncology
CGON
|
$37.5M |
| 5 |
4D Molecular Therapeutics
FDMT
|
$26.2M |
Sector Composition
| 1 | Healthcare | 99.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVA
51
Inventiva
IVA
$861M
| $1.47M | 0.05% | 686,040 | – | – |
|
52
enGene Holdings Inc. Warrants
ENGNW
$7.08M
| $804K | 0.03% | 945,402 | – | – |
|
53
NLS Pharmaceutics
NLSP
$10.4M
| $303K | 0.01% | 143,676 | – | – |
|
|
54
CG Oncology
CGON
$2.04B
| – | – | -994,596 | Closed | -$37.5M |
|
|
55
IDEAYA Biosciences
IDYA
$2.15B
| – | – | -1,409,993 | Closed | -$44.7M |
|
|
56
Ionis Pharmaceuticals
IONS
$6.79B
| – | – | -1,451,879 | Closed | -$58.2M |
|
57
NewAmsterdam Pharma
NAMS
$2.71B
| – | – | -1,521,948 | Closed | -$25.3M |
|
58
VistaGen Therapeutics
VTGN
$102M
| – | – | -2,000,000 | Closed | -$6.02M |
|
|
MTEM
59
DELISTED
Molecular Templates, Inc.
MTEM
| – | – | -522,238 | Closed | -$734K |
|